From July 1, 2020 to September 30, 2020, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 69,714 shares, representing 0.11% for KRW 918.87 million under the buyback announced on March 13, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,610 KRW | +1.16% | -3.87% | -15.53% |
May. 20 | HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
May. 20 | HLB bioStep Co.,Ltd. authorizes a Buyback Plan. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.53% | 163M | |
+15.30% | 3.82B | |
+2.34% | 2.33B | |
-19.52% | 2.02B | |
-20.72% | 1.67B | |
+31.45% | 1.14B | |
+21.58% | 760M | |
-9.39% | 697M | |
-21.63% | 566M | |
-1.29% | 290M |
- Stock Market
- Equities
- A278650 Stock
- News HLB bioStep Co.,Ltd.
- Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.